Related Experiment Video
Updated: Jul 8, 2026
04:16
Whole Body Vibration Methods with Survivors of Polio
Published on: October 17, 2018
Post-poliomyelitis syndrome: clinical features and management
1Department of General Medicine/Care of the Elderly, Llandudno Hospital, Northwest Wales NHS Trust, Llandudno.
British Journal of Hospital Medicine (London, England : 2005)
|January 12, 2008
Summary
Post-polio syndrome primarily impacts women with a history of paralytic polio. Effective management involves accurate diagnosis, non-fatiguing exercises in warm settings, and tailored rehabilitation.
Area of Science:
- Neurology
- Rehabilitation Medicine
- Epidemiology
Background:
- Post-polio syndrome (PPS) is a neurological condition affecting individuals years after recovering from paralytic poliomyelitis.
- PPS predominantly impacts women and can lead to significant functional decline.
- Understanding the specific needs of PPS patients is crucial for effective treatment.
Purpose of the Study:
- To outline the key characteristics of post-polio syndrome.
- To emphasize the importance of accurate diagnosis and appropriate management strategies.
- To highlight the benefits of specific rehabilitation approaches for PPS patients.
Main Methods:
- Review of existing literature on post-polio syndrome.
- Analysis of patient demographics and clinical presentations.
- Evaluation of therapeutic interventions, including exercise and environmental modifications.
Main Results:
- Post-polio syndrome primarily affects women survivors of paralytic polio.
- Patients generally respond well to non-fatiguing exercises conducted in a warm environment.
- Correct diagnosis is essential for implementing effective management and rehabilitation plans.
Conclusions:
- Accurate diagnosis of post-polio syndrome is paramount.
- Non-fatiguing exercises in a warm environment are beneficial for most patients.
- Comprehensive management and rehabilitation are key to improving outcomes for individuals with PPS.
Related Concept Videos
01:17Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:28Pleural Effusion II: Symptoms and Management
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:27Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...